The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

CVS Faces Challenges, Opportunities in Home Dialysis Market. News | By John Commins | April 11, 2018 ...

CVS Health Corp. released its latest corporate social responsibility (CSR) report, Transform Health 2030, that includes goals for engagement with customers and patients, new environmental goals ...

In a bid to put people on the path to better health, CVS Health has made significant changes in its retail stores, such as ending the sale of tobacco products, embracing healthier food options and ...

CVS shares fell 18.3% to $55.36, putting the stock on track to lose over $15 billion in market value. U.S. health insurers have had to contend with rising medical costs over the past few quarters ...

CVS Health’s new CEO, David Joyner, is making leadership changes to address the challenges in the company’s insurance unit, Aetna.These changes were announced at the company’s Q3earnings ...

CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017.

The biggest challenge for CVS in the kidney dialysis market is its lack in-center dialysis. Fresenius Medical Care and DaVita control about 95% of the in-center market, and Curran estimates that 8 ...